Strategies used by helicobacter pylori to establish persistent infection
1Amin Talebi Bezmin Abadi, Department of Bacteriology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran 14115-111, Iran.
Abstract:
Helicobacter pylori (H. pylori) is a Gram-negative and motile bacterium that colonizes the hostile microniche of the human stomach, then persists for the host's entire life, if not effectively treated. Clinically, H. pylori plays a causative role in the development of a wide spectrum of diseases including chronic active gastritis, peptic ulceration, gastric adenocarcinoma, and gastric mucosa-associated lymphoid tissue lymphoma. Due to the global distribution of H. pylori, it is no exaggeration to conclude that smart strategies are contributing to adaptation of the bacterium to its permanent host. Thirty-four years after the discovery of this bacterium, there are still many unanswered questions. For example, which strategies help the bacterium to survive in this inhospitable microniche? This question is slightly easier to answer if we presume the same clinical concept for both persistent infection and disease. Understanding the mechanisms governing H. pylori persistence will improve identification of the increased risk of diseases such as gastric cancer in patients infected with this bacterium. A well-defined and long-term equilibrium between the human host and H. pylori allows bacterial persistence in the gastric microniche; although this coexistence leads to a high risk of severe diseases such as gastric cancer. To escape the bactericidal activity of stomach acid, H. pylori secretes large amounts of surface-associated and cytosolic urease. The potential to avoid acidic conditions and immune evasion are discussed in order to explain the persistence of H. pylori colonization in the gastric mucosa, and data on bacterial genetic diversity are included. Information on the mechanisms related to H. pylori persistence can also provide the direction for future research concerning effective therapy and management of gastroduodenal disorders. The topics presented in the current review are important for elucidating the strategies used by H. pylori to help the bacterium persist in relation to the immune system and the many unfavorable features of living in the gastric microniche.
Insights
Helicobacter pylori (H. pylori) uses urease to survive stomach acid and evade the immune system, enabling lifelong colonization. Understanding these persistence strategies is key to managing H. pylori-related diseases like gastric cancer.
Area of Science:
- Microbiology
- Gastroenterology
- Immunology
Background:
- Helicobacter pylori (H. pylori) is a Gram-negative bacterium colonizing the human stomach.
- H. pylori infection is linked to gastritis, peptic ulcers, and gastric cancer.
- The bacterium's persistence strategies in the harsh gastric environment remain incompletely understood.
Purpose of the Study:
- To elucidate the mechanisms of H. pylori persistence in the human stomach.
- To explore bacterial strategies for surviving acidic conditions and evading immune responses.
- To inform future research on effective therapies for H. pylori-related gastroduodenal disorders.
Main Methods:
- Review of scientific literature on H. pylori survival mechanisms.
- Analysis of bacterial adaptations to the gastric microniche.
- Discussion of urease activity, immune evasion, and genetic diversity.
Main Results:
- H. pylori secretes urease to neutralize stomach acid, facilitating survival.
- Bacterial immune evasion strategies contribute to long-term colonization.
- Genetic diversity plays a role in H. pylori's adaptation and persistence.
Conclusions:
- H. pylori employs sophisticated strategies, including urease production and immune evasion, for persistent colonization.
- Understanding these mechanisms is crucial for identifying individuals at high risk for H. pylori-associated diseases.
- Further research into H. pylori persistence can guide the development of novel therapeutic interventions.
Related Concept Videos
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Viral Replication: Lysogenic Cycle
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Lysogenic Cycle of Bacteriophages


